Physicians caring for the society
MD Pharma Consulting Group
Physicians caring for the society
"We streamline clinical operations to deliver efficacious solutions for complex projects."
"Vigilance is our key for patient safety."
Bassem graduated in medicine and has worked in clinical medicine as an oncologist, in academia, and in the pharmaceutical industry over the past 20 years. His experience has been primarily in oncology, pharmacovigilance, clinical research, and lab research. He holds an MSc degree in Experimental Therapeutics at the University of Oxford, UK and an MSc degree in Experimental Medicine at McGill University, Canada. He is a Ph.D. candidate in health technology assessment at the University of Toronto, Canada. Bassem is a pharmacovigilance consultant, a clinical research instructor, a graduate teaching assistant, and a lead medical writer at the University of Toronto, Canada. Bassem’s areas of research are health technology assessment, decision analysis, and benefit-risk assessment.
Contact Dr. Toeama:
Phone: +20 112 2257818
"Going above and beyond the expectations of MD Pharma Consulting Group stakeholders is our game-changer in the pharmaceutical, biotechnology, and healthcare industry."
Ahmed Sherbiny graduated in Medicine, he is an MBA holder majoring in finance from the University of Portland, USA. He has worked in Business Development, Outreach, Healthcare and Hospital Management, and Health Financing. He is the section head of Institutional Advancement at Children’s Cancer Hospital Egypt 57357. He has shared in many healthcare reform projects related to the Egyptian Ministry of Health. Ahmed's areas of research include preventive and public health affairs, healthcare insurance, and resource allocation in healthcare.
Contact Dr. Sherbiny:
Phone: +20 100 1108506
"We ensure to deliver quality services and best in class solutions to our clients."
Rani Parihaar is an experienced Operations Director who provides visionary leadership to MD Pharma Consulting Group global team. She has more than 10 years of experience in Information Technology, Pharmacovigilance and Clinical Research. She received her Bachelor of Science degree in biotechnology and is a post-graduate in Clinical Research, Data Management, and Pharmacovigilance from the AAPS and Project Management from the University of Toronto. Rani was part of many successful clinical trials, Pharmacovigilance projects, Data Management and also worked for some of the top Fortune 500 companies. She is certified in EudraVigilance from the EMA, United Kingdom. She believes that constant learning is the key to success. Rani's areas of interest are science and technology.
Contact Rani Parihaar:
"Making a radical change in the medical community is always challenging, but everything is possible with MD Pharma Consulting Group."
Katreen Mikhail graduated with a bachelor’s degree in Science majoring in chemistry and biochemistry – Pre-medical from Montana State University, USA. She took part in the research experience for undergraduates (REU) where she worked on different biological and biochemical research projects. Moreover, Katreen participated in clinical trials where she had experience in the fields of clinical research and data management. She had a couple of internships at different hospitals where she helped with data collection and analysis to achieve valid results. She also has experience in medical writing. Katreen's areas of research include health research evaluation and assessment.
Contact Katreen Mikhail:
Phone: +20 122 3781978
"We help scientists achieve their goals."
Gamal Eldein has graduated in biological sciences and has worked in cancer biology and anti-cancer drug development as a researcher, in academia, and in the pharmaceutical industry over the past 15 years. His experience has been primarily in oncology, molecular medicine, metabolomics, lab research and animal research. He holds an MSc degree in Physiology at Beni-Suef University, Egypt, and a Ph.D. in Molecular Medicine at Torino University, Italy and Integrated Molecular Physiology at Cairo University, Egypt. He is a research fellow in Basic Science Cancer Research at Salamanca University, Spain. Gamal Eldein is a molecular medicine consultant, a lead medical writer, a peer reviewer, and a metabolomics expert at the National Research Centre, Egypt. Gamal Eldein's areas of research are cancer biology, metabolomics analysis, molecular biology techniques, and xenograft models.
"We analyze data to infer statistically significant solutions for our stakeholders."
Nermin Osman graduated in Medicine, she is a Ph.D. holder and staff member of Biomedical Informatics and Medical Statistics at the Medical Research Institute, Alexandria University, Egypt. She mastered a degree in Public Health Policy as a joint degree with the United Nations Institute for Training and Research (UNITAR) after being selected as the United Nations System Staff College Intern in 2017. She has worked in the field of epidemiological studies and statistics over the past 10 years. She is a research fellow in the Data Science Institute, Imperial College London, UK. Nermin is a biostatistician, research methodology consultant, and a clinical research instructor; she has shared in many research projects related to the World Health Organization, International Labor Office, United Nations Statistics Division, and Erasmus Plus. Nermin’s areas of research are epidemiological surveys, clinical trials, critical appraisal of different studies, big data analysis, and statistical modelling.
"We provide evidence-informed decision making in health care through applying principles of health technology assessment and health policymaking."
Nermeen Ashoush graduated in pharmacy and is working as an Assistant Professor in the Clinical Pharmacy Practice Department and Head of Health Economics Unit, Center for Drug Research and Development, The British University in Egypt. She earned her master’s and doctorate degrees in Clinical Pharmacy Practice from Ain Shams University. She studied Health Economics and Outcomes Research at the University of Washington, Seattle, Washington and has several publications in prominent clinical pharmacy and health economics journals as well as co-authored a book in Market Access, Pharmaceutical Pricing and Healthcare Costs. She has been an invited speaker to several workshops in Health Economics and Outcome Research in the MENA region and an invited speaker to several international conferences. Nermeen’s areas of research are clinical trials,
economic modelling, health technology assessment, budget impact analysis and health policy.